Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: Dec 5, 2025, 4:00 PM EST
2.670
-0.010 (-0.37%)
After-hours: Dec 5, 2025, 7:55 PM EST

Milestone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
27215672169276200
Upgrade
Market Cap Growth
141.76%117.39%-57.49%-38.80%38.33%-49.05%
Upgrade
Enterprise Value
247134479515198
Upgrade
Last Close Price
2.682.361.673.966.556.70
Upgrade
PS Ratio
--71.9133.8318.43-
Upgrade
PB Ratio
13.2811.894.292.552.461.40
Upgrade
P/TBV Ratio
13.2811.894.292.552.461.40
Upgrade
EV/Sales Ratio
--47.1918.9010.05-
Upgrade
Debt / Equity Ratio
2.794.173.090.040.010.01
Upgrade
Asset Turnover
--0.010.050.11-
Upgrade
Quick Ratio
7.998.799.3410.7216.9223.26
Upgrade
Current Ratio
8.249.1010.1111.7017.5524.14
Upgrade
Return on Equity (ROE)
-260.65%-277.55%-143.61%-65.26%-33.52%-38.73%
Upgrade
Return on Assets (ROA)
-41.97%-34.92%-51.01%-38.36%-19.95%-23.18%
Upgrade
Return on Capital (ROIC)
-45.93%-38.56%-55.59%-40.93%-20.92%-24.43%
Upgrade
Return on Capital Employed (ROCE)
-74.10%-62.50%-89.80%-87.30%-38.10%-35.30%
Upgrade
Earnings Yield
-21.31%-26.56%-83.00%-34.52%-15.50%-25.01%
Upgrade
FCF Yield
-15.85%-18.48%-64.72%-31.18%-12.02%-25.39%
Upgrade
Buyback Yield / Dilution
-31.08%-44.82%-1.19%-1.47%-42.56%-85.91%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.